Skip to main
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 10 analyst ratings
Hold
Strong Buy 10%
Buy 20%
Hold 70%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT is a stable and promising investment opportunity due to its strong fundamentals, including rising demand for healthcare facilities driven by demographic trends, limited new supply, and a strong balance sheet with good liquidity. Additionally, SBRA's recent agreements with Avamere and RCA demonstrate its ability to secure favorable lease terms and manage risk effectively. The company's focus on growing its SHOP portfolio and the strong outlook for the senior housing transaction market also contribute to a positive outlook.

Bears say

Sabra Health Care REIT is likely to face some challenges in the near future due to the rental cuts received by some of its tenants in 2022 and an increase in rent for its portfolio. This could potentially have a negative impact on its FFO and normalized FFO estimates for 2026 and 2027. The company also faces risks related to its tenants' operating performance, government regulations, and reimbursements, as well as competition and its debt levels.

SBRA has been analyzed by 10 analysts, with a consensus rating of Hold. 10% of analysts recommend a Strong Buy, 20% recommend Buy, 70% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 10 analysts, SBRA has a Hold consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.90, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.90, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.